About
About
About
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
​
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
​
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
​
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
​
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
​
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
​
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
​
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
​
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
​
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
​
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
​
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
​
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma
Code Pharma’s Gammora®: A Breakthrough Toward a Potential HIV Cure
Code Pharma's Gammora® Shows Promising Results in HIV Cure
DE BILT, Netherlands & GLASGOW, Scotland — Code Pharma revealed positive outcomes from an eight-week study of its HIV drug, Gammora®, indicating potential for a cellular-level cure. These groundbreaking results were unveiled at the HIV Drug Therapy 2024 Conference in Glasgow.
Promising Results for Gammora® in the Fight Against HIV
Breakthrough in HIV Research: Gammora®'s Positive Findings
Code Pharma announced encouraging results from an eight-week trial of Gammora®, its HIV-treatment drug. Presented at the HIV Drug Therapy 2024 Conference, these findings highlight a potential cure for HIV at the cellular level.
Hope on the Horizon: Gammora® Shows Favorable Outcomes Against HIV
Gammora® by Code Pharma: Paving the Way Toward an HIV Cure
Positive eight-week results for Gammora®, Code Pharma’s innovative HIV drug, suggest it may cure the virus at the cellular level. Preliminary data was shared during the HIV Drug Therapy 2024 Conference in Glasgow.
Code Pharma Leads the Way: Gammora® Moving Closer to an HIV Cure
Hope for HIV Cure: Code Pharma Shares Promising Gammora® Data
In a groundbreaking announcement, Code Pharma reported positive results from an eight-week study of its HIV drug, Gammora®, showcasing potential for a cellular-level cure. Findings were presented at the 2024 HIV Drug Therapy Conference.
Gammora® Achieves Breakthrough Results in HIV Treatment Progress
Code Pharma’s Gammora®: A Step Closer to HIV Eradication
At the HIV Drug Therapy 2024 Conference, Code Pharma unveiled promising eight-week trial results for Gammora®, its HIV drug. The findings suggest a significant advancement toward a cellular-level cure for HIV.
Global Trend Monitor
We were featured in the Global Trend Monitor, a UAE-based business & lifestyle magazine!
Read the interview with our founder & CEO Zyon Ayni and find out how Zyon founded Code Pharma to develop ground-breaking medical solutions as well as the promising results of our clinical trials regarding Codivir, its safety and effectiveness.
Events
10-13 December 2024
Code Pharma presents at the HIV Persistence During Therapy Workshop
taking place at Miami, Florida - USA.
The company will present preliminary results of a clinical trial
10-13 November 2024
Code Pharma presents at the HIV Drug Therapy 2024 Conference
taking place at Glasgow, Scotland.
The company will present preliminary results of a clinical trial